The promising result on early-stage trials of AstraZeneca’s potential COVID-19 vaccine, which is expected to be announced as early as today, could boost demand for the stock. However, many will eye the response of T cells in research as it is expected to be an important defence against coronavirus.
Post Top Ad
Your Ad Spot
Thursday, July 16, 2020
Home
Yahoo Finance
AstraZeneca Promising Result on COVID-19 Vaccine to Boost Stock; Target Price GBX 10,970
AstraZeneca Promising Result on COVID-19 Vaccine to Boost Stock; Target Price GBX 10,970
Subscribe to:
Post Comments (Atom)
Sponsor
Ad Banner
Your Ad Spot
Author Details
Rathore Post covers What’s happening in the world. News, Politics, Business, Entertainment, Sports, Latest Technology about software, mobile ,computer science, internet, semiconductor, telecom and science, Latest Modern Fashion news, Modern Beauty Information, Health Disease Information & Home treatment Remedies & Affiliate marketing program in all of our journalism.

No comments:
Post a Comment